INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 28 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,290,000 | -6.9% | 2,464,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,459,000 | -2.8% | 2,464,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,530,000 | -0.7% | 2,464,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,549,000 | -0.9% | 2,464,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,573,000 | +16.7% | 2,464,000 | +24.4% | 0.00% | +50.0% |
| Q1 2021 | $2,205,000 | -0.3% | 1,981,000 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $2,211,000 | -19.6% | 1,970,000 | -22.3% | 0.00% | -33.3% |
| Q3 2020 | $2,750,000 | -18.3% | 2,534,000 | -26.8% | 0.00% | -25.0% |
| Q2 2020 | $3,366,000 | +16.4% | 3,463,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,892,000 | -13.3% | 3,463,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,336,000 | +54.1% | 3,463,000 | +33.3% | 0.00% | +33.3% |
| Q3 2019 | $2,165,000 | +85.4% | 2,597,000 | +115.9% | 0.00% | +200.0% |
| Q2 2019 | $1,168,000 | -43.6% | 1,203,000 | -41.3% | 0.00% | -66.7% |
| Q1 2019 | $2,071,000 | -0.7% | 2,051,000 | -30.0% | 0.00% | 0.0% |
| Q4 2018 | $2,086,000 | – | 2,929,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |